文献速递新发突发、热带与寄生虫病

埃博拉病:连接科学发现与临床应用

Ebola disease: bridging scientific discoveries and clinical application.
PubMed 文献 · Lancet Infect Dis · 2024-12-12

本文为两部分系列文章的第一篇,回顾了2014-16年西非埃博拉病疫情对患者护理的教训,总结了此后十年在埃博拉病临床护理方面的显著成就,包括首批疫苗和治疗药物的批准,并提供了埃博拉病现代概貌的专家总结,强调了进一步提高患者生存率和福祉的优先事项与持续活动。

要点

  • 2014-16年西非埃博拉病疫情暴露了全球应对架构在快速传播疫情中的不足。
  • 此后十年埃博拉病临床护理取得显著成就,包括首批疫苗和治疗药物获批。
  • 本文强调进一步提高埃博拉病患者生存率和福祉的优先事项与持续活动。

核心结论

  • 自2014-16年西非埃博拉病疫情以来,埃博拉病临床护理取得显著成就,包括首批疫苗和治疗药物获批。

研究设计与样本

  • 本文为两部分系列文章的第一篇,属专家总结与回顾性文章。

主要发现

  • 2014-16年西非埃博拉病疫情在许多方面应对失败,全球架构缓慢、笨拙且脱节,不适合快速传播的疫情。
  • 在最受影响的国家,卫生保健工作者和其他响应者感到无助,面对大量患者但几乎没有工具提供高质量护理。
  • 这些不足带来了关注和创新,此后十年埃博拉病临床护理取得显著成就,包括首批疫苗和治疗药物获批。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The west Africa Ebola disease epidemic (2014-16) marked a historic change of course for patient care during emerging infectious disease outbreaks. The epidemic response was a failure in many ways-a slow, cumbersome, and disjointed effort by a global architecture that was not fit for purpose for a rapidly spreading outbreak. In the most affected countries, health-care workers and other responders felt helpless-dealing with an overwhelming number of patients but with few, if any, tools at their disposal to provide high-quality care. These inadequacies, however, led to attention and innovation. The decade since then has seen remarkable achievements in clinical care for Ebola disease, including the approval of the first vaccines and treatments. In this paper, the first in a two-part Series, we reflect on this progress and provide expert summary of the modern landscape of Ebola disease, highlighting the priorities and ongoing activities aimed at further improving patient survival and wellbeing in the years ahead.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Rojek A, Fieggen J, Apiyo P, et al. Ebola disease: bridging scientific discoveries and clinical application. Lancet Infect Dis. 2024. PMID: 39675368. doi:10.1016/S1473-3099(24)00673-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。